Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Surefire CPR Announces New Management Of Assaultive Behavior (MAB) Online Certification Course


SureFire CPR

SureFire CPR

Completing a MAB certification course is highly recommended for all healthcare professionals that deal with individuals who may become violent.

SureFire CPR, an organization dedicated to high-quality education in first aid and cardiopulmonary resuscitation, is pleased to announce a new online certification course in Management of Assaultive Behavior (MAB). This potentially life-saving course is designed to help health care professionals develop violence prevention skills that can be implemented in a variety of settings.

“Completing a MAB certification course is highly recommended for all healthcare professionals that deal with individuals who may become violent,” says Zack Zarrilli, Founder. “In the state of California, this annual certification is required for anyone working in an Emergency Room or psychiatric unit.”

Conducted entirely online, this course takes up to four hours to complete and meets AB-508, SB-1299, and California State law requirements. The main educational focus involves learning non-physical conflict intervention strategies.

To register for SureFire CPR’s MAB online certification course, please visit https://www.surefirecpr.com/mab-certification/.

About SureFire CPR:

SureFire CPR offers professional, affordable and convenient CPR instruction to the greater Southern California area. At their industry-leading training facilities in Orange County, Los Angeles County, and Riverside County, CPR classes and other certification programs are available to the public and taught by professional firefighters, paramedics, lifeguards, ER nurses and EMTs. SureFire CPR also offers onsite training and CPR certification in Southern California for those wishing to learn at their home or business. They also now provide online training for continuing education. To learn more, visit https://www.surefirecpr.com/.

Share article on social media or email:

Stores Must Transform Their Environments to Meet the New Realities of Retail


DisplayMax Retail Renewal

DisplayMax Retail Renewal Installation

Retail store floor plans were not designed with a contagious health crisis in mind.

The new realities of retail are unfolding daily within every marketing channel as the country enters into the next phase of the Coronavirus crisis. With shutdowns being lifted and shoppers beginning to return, the critical issue facing retailers is whether customers will have the trust and confidence to safely enter their doors again.

“Many retailers have implemented temporary, stop-gap measures to open their businesses again,” says Charlie Domen, president of Displaymax Retail Services. “But are stores prepared to face the long term challenges of promoting social distancing and infection control when the next predicted wave of Covid-19 occurs? Will retailers have the permanent measures in place that ease customer’s fears?”

Studies have shown that many customers have serious reservations about shopping again and will not experience a sense of “normal” for the foreseeable future. Due to the ongoing pandemic, shopper behavior has changed forever and the temporary safety measures that have been put into place will need to remain in place for some time.

“Retail store floor plans were not designed with a contagious health crisis in mind. That’s why our team identified three key areas where the sales floor can be transformed to help build a line of defense which promotes customer and employee safety,” explains Jennifer Crouch, Business Development Manager. “We developed a list of specific action areas that store operations can easily implement to make permanent upgrades to address the issues. We call these our Retail Renewal strategies.”

Retail Renewal is a collection of practical strategies that address these three critical aspects of operating in a Covid-19 world: Customer Flow, Checkout Areas, and Customer Safety.

  • Customer Flow: Encourage social distancing by creating more space through realigning gondolas and displays, constructing half wall dividers, installing new directional signage and resetting category planograms.
  • Checkout Areas: Improve safety and efficiency by installing new technology, adding queuing line fixtures, curbside pickup area, refitting checkout counters and adding protective sneeze guards.
  • Customer Safety: Install permanent measures with high quality hand sanitizer stands, adding shopping cart sanitizing stations, upgrading restroom doors to hands free openers and installing automatic restroom dispensers.

“Some of these areas may have been part of the initial response stores had to the pandemic,” Crouch explains. “But a more comprehensive approach is necessary for long term mitigation. Retailers who make customers feel most comfortable and safe are going to win this invisible war and the Retail Renewal program provides many of the solutions.”

At the core of Retail Renewal is executing upgrades at a single store location at one time. This alleviates the “piece meal” approach that produces gaps within a store’s efforts to create a safer environment. “We provide all the products and installation services so retailers can implement the upgrades at once,” Crouch adds. “Our approach is a turnkey solution that includes the procurement, warehousing and distribution of all specified materials. We can also schedule multiple teams to install a package of new safety measures in stores for nationwide chains to a single store on Main Street.”

As many retailers struggle with implementing safety measures, the Retail Renewal approach gives them the resources they need to meet the next phase of the pandemic no matter how severe. Domen explains, “With our years of experience providing services to retailers, we understand that many stores need help executing these critical safety measures. Managers are so busy dealing with staffing issues and keeping product on the shelves that these can fall to the bottom of the to-do list. We want to help them make the upgrades and be prepared for the new realities they will face.”

More details about Retail Renewal can be found at https://DisplayMaxInc.com

About:

DisplayMax Retail Services has been providing in-store merchandising, installation and store fixtures to retailers throughout the Unites States since 1991. Working with large big box chains to small independent retailers, our goal for every project entrusted to us is 100% compliance execution.

Share article on social media or email:

Cherokee Legal Holdings Announces the Launch of Gain Servicing, Relief for Healthcare Practices Amidst COVID-19


gain servicing

gain servicing

Today, Cherokee Legal Holdings (“Cherokee”), a full-service direct legal and medical services company, providing financial assistance for plaintiffs, payment for medical care and the servicing of third-party, torte action receivables for medical providers, announced the launch of gain servicing, https://www.gainservicing.com, a wholly owned subsidiary of Cherokee.

Cherokee, a founding member of Americans for Patient Access (APA) advocating for patient care regardless of health insurance coverage, was founded in 2010 and is one of the fastest growing funding companies in the U.S. In 2019, Cherokee piloted an artificial intelligence initiative to increase patient data analysis and accelerate the financial returns produced for healthcare practices. Gain servicing now offers these services to healthcare providers directly.

Gain servicing provides the management of certain third-party liability claims including Letters of Protection (LOPs) and the management of third-party liens on behalf of healthcare practices, which enables doctors to focus less on their accounts receivables and more on treating patients, regardless of those patients’ medical coverage.

“Doctors are passionate about patients having access to proper treatment, whether they have health insurance or not. As a result, many practices treat uninsured and underinsured personal injury patients on an LOP. This is a ‘win’ for these patients who get needed medical treatment they may not otherwise receive. Meanwhile, treating patients on LOPs is financially hard on doctors. Many have to wait months and even years in the hopes they will get paid when the patient’s case settles. For these very situations, we have created gain servicing to manage these cases from inception to repayment,” said Cherokee CEO, Reid Zeising. “Amidst the COVID-19 outbreak, this service has proven especially critical to many practices that have seen elective procedures slow and may already be stretched thin financially.”

Gain servicing offers a package of technology, people and processes that have proven to deliver higher reimbursements at a lower cost without impacting patient referrals. Gain servicing’s proprietary platform uses machine learning to analyze case information, track LOPs and predict settlement values, thus granting access to needed medical treatment for plaintiffs in tens of thousands of underlying lawsuits. The comparative data simultaneously fuels the artificial intelligence (AI) engine that the gain servicing team then uses to optimize the repayment of rates for LOP cases.

About gain servicing

Gain servicing specializes in the servicing and financing of personal injury patient receivables. Gain servicing experts handle day-to-day, transactional accounts receivables functions on behalf of medical practices while office staff and providers focus on delivering exceptional care and services to patients.

Gain servicing’s technology platform is powered by artificial intelligence and is built to track, manage and optimize returns from Letter of Protection (LOP) account balances. Gain servicing’s financial solutions can provide immediate cash flow and the highest returns on a healthcare practice’s assets. Gain servicing’s solutions are proven to provide higher returns – at lower costs – than if a practice were to manage this service in-house or through other LOP financing options.

To learn more, go to http://www.gainservicing.com.

Share article on social media or email:

Advancements with Ted Danson to Explore How Machine Learning is Improving Healthcare


News Image

“We are giving business owners the necessary tools to improve employee health outcomes and thus reducing costly insurance premiums,” said Sergei Polevikov, CEO of WellAI.

In September of 2020, Advancements with Ted Danson will focus on recent improvements in healthcare research tools and technologies. Check local listings for more info.

With a look at the healthcare system in the U.S. and the vast number of people impacted each year as a result of inefficiencies, this segment of Advancements will explore how WellAI is using Artificial Intelligence (AI) and machine learning to provide early discipline and diagnosis for improved health outcomes.

Viewers will hear from experts in the field and will learn from scientists about this AI-powered application, which uses machine learning algorithms to read and summarize vast amounts of medical literature in order to provide a flexible and structured approach.

“Making healthcare comprehensive and accessible to everyone is what we deeply care about. We were inspired by the Call to Action by the White House Office of Science and Technology Policy on March 16, 2020. That pushed our team to develop WellAI’s COVID-19 research tool, a publicly available platform for medical researchers worldwide. In addition to aiding COVID-19 research, our team is currently focusing on fixing the U.S. healthcare system from the inside out. Specifically, we are giving business owners the necessary tools to improve employee health outcomes and thus reducing costly insurance premiums,” said Sergei Polevikov, CEO of WellAI.

The show will also uncover how WellAI apps are able to accept medical findings, ask follow-up questions, and suggest evidence-based paths for improving health outcomes, while helping scientists to quickly find promising research pathways related to pandemics, like that of COVID-19.

“Using its most powerful technology and data science resources, WellAI’s broader machine learning analytics tool compiles and analyzes over 25 million studies to improve health outcomes,” said DJ Metzer, senior producer for the Advancements series. “We look forward to exploring this technology.”

About WellAI:

WellAI, LLC is a health and technology company dedicated to changing the way companies and individuals think about healthcare by empowering people in pursuit of wellness through the use of AI models and blockchain databases. WellAI helps employers improve group benefits, reduce health insurance costs for businesses and employees, and create healthier teams. WellAI apps are able to accept medical findings, ask follow-up questions, and suggest evidence-based paths for improving health outcomes. While WellAI personal health applications are not meant to replace doctors, they can serve as an additional resource for those who want to understand and improve their health using evidence-based science. For more information, call 307-278-1819 or visit https://wellai.health.

About Advancements and DMG Productions:

The Advancements series is an information-based educational show targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today’s consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming on which both viewers and networks depend.

For more info, please visit: http://www.AdvancementsTV.com or call DJ Metzer at 866-496-4065.

Share article on social media or email:

Apex Learning Brings Critical Social and Emotional Learning and Mental Health Programming to Districts through Partnership with Evolution Labs


News Image

“This partnership with Suite360 allows us to continue to provide standards-aligned, student centered learning backed by powerful efficacy data, now with the ability to offer essential life skills supporting the needs of the whole child.” -Chris Porter, CEO, Apex Learning

Apex Learning, a recognized leader in online learning for secondary education, today announced a partnership with Evolution Lab s, a leader in social-emotional learning (SEL) devoted to engaging students in positive SEL outcomes through their industry leading Suite360 solution. This partnership provides districts with SEL and mental health resources to support student emotional health and well-being.

“Effective SEL resources equip students with life skills and strategies for managing stress and change while building perseverance and resilience—all skills that are important, particularly in the midst of the challenges we are experiencing today,” said Chris Porter, CEO, Apex Learning. “To fully support the academic needs of students, we must also support their social and emotional needs. This partnership with Suite360 allows us to continue to provide standards-aligned, student centered learning backed by powerful efficacy data, now with the ability to offer essential life skills supporting the needs of the whole child.”

The Suite360:Student program covers a wide range of SEL and mental health issues, including bullying, digital citizenship, conflict resolution, respect, racial tolerance, anxiety, academic pressure, vaping and drug and alcohol awareness. Suite360:Mental Health covers strategies for healthy coping skills, reducing stigma, awareness of mental health resources and suicide prevention. Suite360:Intervention provides restorative programming to students who commit infractions. Suite360:Parent and Suite360:Staff assure that all stakeholders are involved and equipped to help students be successful.

Web and mobile Suite360 lessons are available in multiple languages. Suite360 offers research and evidence-backed learning materials mapped to the standards developed by the National Collaborative for Academic, Social, and Emotional Learning (CASEL) and designed to meet grade-level learning objectives.

All Suite360 programs can be accessed in school or at home on any web-enabled device, and they all include Suite360 programs include Pulse surveys. These surveys provide a snapshot of student dispositions, attitudes and school climate throughout the year.

“We immediately recognized the synergy between Apex Learning and our core values, putting students at the center of their learning with standards-aligned content demonstrating proven student outcomes,” said Peter Kraft, Founder and President, Evolution Labs. “We believe this partnership will continue to expand our reach to provide more students with access to social, emotional and mental health strategies – critical skills needed for academic and social success.”

To learn more, visit: https://www.apexlearning.com/social-emotional-learning.

About Apex Learning

An industry leader in online education with deep expertise in digital curriculum, Apex Learning works closely with school districts across the country to implement proven solutions that increase on-time graduation rates and create opportunities for student success in school and beyond. The company is driven by the understanding that supporting the needs of all students – from struggling to accelerated – strengthens schools and creates stronger communities, brighter futures and a more equitable world. Apex Learning is accredited by AdvancED and its courses are approved for National Collegiate Athletic Association eligibility. Apex Learning, where opportunity thrives. For more information, visit http://www.apexlearning.com

Share article on social media or email:

Béla Wellness Infusion Launches in Albertsons TX and NM, and Better Health MI


Béla – Tropical Flavor

“We are on our way to becoming a national brand”

Béla, the Atlanta-based wellness beverage brand, announced that it has launched in Albertsons’ United Supermarkets in Texas and New Mexico, as well as The Better Health Stores in Michigan. Béla will also expand its national presence further with KeHE’s New@KeHE program in August.

“We are really excited to take our first steps towards truly becoming a national brand, and are really grateful to Albertsons’ United and Better Health Stores for giving us the opportunity,” said Atul Agarwal, Béla’s Founder and CEO, adding “Given the challenging environment, we are supporting the roll-out with a sustained marketing and sales activation plan through the year to drive trial and velocity.”

Béla will also launch across multiple states in August through KeHE’s New@KeHE program, involving 5 Distribution Centers – Lehigh Valley, Bloomington, Romeoville, Chino and Flower Mound.

“KeHE gave us the first breakthrough by approving us for the Innovation Pipeline at their 2020 Summer Show earlier this year, and we want to build a strong partnership with them,” said Atul, adding, “These 5 distribution centers span markets where we have seen the most demand for Béla in our Direct channels, and the New@KeHE program is a great way for us to expand into those markets.”

The company raised a Seed Round of $515K recently, also adding two senior industry executives as Advisors. Atul added, “We will be looking to raise a Series A round over the next 12-18 months as we continue to build our brand, product suite and geographic presence”.

Born out of a personal need of the founder-couple, Béla combines time-tested ingredients like Turmeric, Tulsi, Ginger and Amla with minerals and vitamins in 0 sugar, 0 calorie blends. The combination of ingredients is inspired by holistic mind-and-body wellness, and work to support immunity, promote calming, support energy and optimal hydration. Launched in 2018 in Atlanta, GA, Béla was enthusiastically embraced by Atlanta’s yoga and wellness community, and expanded to LifeCafe fast casual restaurants in Life Time’s athletic resort destinations nationwide in 2019. The company embarked on national retail expansion in 2020, fueled by the success among its core demographic of active women aiming for holistic wellness.

About Béla – Harmony in Hydration

Béla is a brand owned by Althea Brands, founded and headquartered in Atlanta, GA. Althea Brands combines traditional medicine and wellness knowledge with contemporary scientific research to develop natural and healthy foods and beverages. The company is a Certified Minority Business, and contributes a portion of every sale to support girls’ health & empowerment. The company also offsets 100% of the carbon-footprint of shipments to distributors and retailers, and aims to be carbon-neutral by 2021. Learn more about Béla at https://drinkbela.com, and follow on Instagram (@drinkbela) and Facebook (@drinkbela).

Share article on social media or email:

Catalent Partners with ViralClear Pharmaceuticals on Potential Treatment for COVID-19


We are pleased to be working with Catalent that has already manufactured clinical trial materials of our merimepodib oral solution for the current Phase 2 clinical trial and is performing further product development on liquid-filled oral formulations.

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has signed an agreement with ViralClear Pharmaceuticals, Inc. (ViralClear), a subsidiary of BioSig Technologies, to work on the development of a potential treatment for adults with advanced Coronavirus Disease 2019 (COVID-19). Under the terms of the agreement, Catalent will be developing two oral dosage forms of ViralClear’s broad-spectrum anti-viral agent, merimepodib: a solution and a solid oral dosage form.

ViralClear is undertaking research to investigate the potential of Merimepodib to fight the SARS-CoV-2 virus, either as a standalone treatment, or in combination with other anti-viral agents or immune modulators.

“We are pleased to be working with Catalent that has already manufactured clinical trial materials of our merimepodib oral solution for the current Phase 2 clinical trial and is performing further product development on liquid-filled oral formulations,” commented Steve King, Chief Operating Officer of ViralClear. He continued, “ViralClear is committed to using US-based contract development and manufacturing organizations for the development and commercialization of merimepodib.”

Catalent will work on the program at its St. Petersburg, Florida, facility, manufacturing oral solution for clinical studies, as well as undertaking feasibility studies on other liquid-filled oral formulations.

“Finding treatments for the pandemic we are faced with is a global priority, and, as a world leader in softgel development and manufacturing, Catalent is ideally suited to work on this program with ViralClear,” commented Dr. Aris Gennadios, President, Softgel & Oral Technologies. “Our expertise and more than 85 years of experience in lipid-based formulation will facilitate rapid clinical manufacturing and provide drug product that can be tested against the threat the virus poses as soon as possible.”

Catalent’s 453,000-square foot facility at St. Petersburg is its primary softgel development and manufacturing facility in the U.S., with a capacity of 18 billion capsules per year.

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 13,500 people, including over 2,400 scientists and technicians, at more than 40 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

About ViralClear Pharmaceuticals, Inc. and Merimepodib (MMPD)

BioSig Technologies, Inc.’s (Nasdaq: BSGM) subsidiary, ViralClear Pharmaceuticals, Inc., is seeking to develop a novel pharmaceutical called merimepodib to treat patients with COVID-19. Merimepodib is intended to be orally administered, and has demonstrated broad-spectrum in vitro antiviral activity, including strong activity against SARS-CoV-2 in cell cultures. Merimepodib was previously in development as a treatment for chronic hepatitis C and psoriasis by Vertex Pharmaceuticals Incorporated (Vertex), with 12 clinical trials (7 in phase 1 and 5 in phase 2) with over 400 subjects and patients and an extensive preclinical safety package was completed. A manuscript titled, “The IMPDH inhibitor merimepodib provided in combination with the adenosine analogue remdesivir reduces SARS-CoV-2 replication to undetectable levels in vitro”, was submitted to an online peer-reviewed life sciences journal. This manuscript is authored by Natalya Bukreyeva, Rachel A. Sattler, Emily K. Mantlo, John T. Manning, Cheng Huang and Slobodan Paessler of the UTMB Galveston National Laboratory and Dr. Jerome Zeldis of ViralClear Pharmaceuticals, Inc. (“ViralClear”) as a corresponding author. This article highlights pre-clinical data generated under contract with Galveston National Laboratory at The University of Texas Medical Branch.

Share article on social media or email:

LaVoieHealthScience Forms Strategic Alliance with Bioscience Valuation BSV GmbH


“We look forward to working with Joachim and the BSV team to help our clients succeed, by helping them effectively communicate their true value proposition to investors, licensing partners and other key stakeholders,” said Donna L. LaVoie, President, CEO, and Founder of LaVoieHealthScience.

LaVoieHealthScience (“LHS”) and Bioscience Valuation BSV GmbH (“BSV”) today announced a strategic alliance between the two firms. The alliance combines LHS’ expertise in strategic communications for companies at the forefront of health and science innovation with BSV’s skill in providing strategic valuation assessments for life science companies. The strategic alliance is the second signed in 2020 for both firms. On January 9, 2020, LHS inked a global strategic alliance with Omnicom Public Relations Group (OPRG), a division of Omnicom Group, bringing clients a broader set of integrated health-and science-experienced teams.

Bioscience Valuation provides evidence-based value, commercial, R&D, and economic assessments to pharmaceutical and biotechnology companies to support investment and partnering decisions. With more than 500 life-science and healthcare consulting engagements undertaken by BSV since its founding in 2000, the firm’s evidence-driven analyses help company management validate and communicate the value of their businesses to stakeholders and investors.

“Our strategic alliance with BSV will ensure that LHS clients have a roadmap for understanding the value of their strategic assets,” said Donna L. LaVoie, President, CEO, and Founder of LaVoieHealthScience, “We look forward to working with Joachim and the BSV team to help our clients succeed, by helping them effectively communicate their true value proposition to investors, licensing partners and other key stakeholders.”

Dr. Joachim Greuel, MBA, Managing Director and Co-Founder of Bioscience Valuation BSV GmbH said, “We are excited to work closely with LHS and their clients. Companies must be able to communicate the value of their products based on market evidence to succeed in the life science sector. This strategic alliance will help LHS’ clients maximize value in licensing deals and funding rounds, optimize investment decisions, and better assess the competitive landscape. And it will give our clients access to LHS’ strategic communications and IR programming capabilities to communicate their company’s value proposition to the marketplace.”

About LaVoieHealthScience

LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications, relationship building and marketing. The firm provides strategic consulting, public relations and investor relations to build recognition and increase sales and value for health science innovations and has two trademarked methodologies for its strategic communications’ advisory services. The agency has received over 50 awards in recognition of the work done by its strategic thinkers for health and science industry-leading clients. LHS was inducted in the 2018 Inc. 5000 Hall of Fame List of Fastest Growing Private Companies, as well as ranked on the O’Dwyer’s list of 2020 Healthcare Public Relations Firms and Boston Business Journal’s Largest PR Firms in Massachusetts.

About Bioscience Valuation BSV GmbH

Founded in 2000, Bioscience Valuation BSV GmbH is a leading life science valuation company operating on a global scale. The company uses its sharp quantitative analysis skills to help clients in the healthcare sector asses the economic value of their products and communicate the findings in an optimal way. The services provided by Bioscience Valuation form the foundation for a well-informed, highly rational and value-maximizing strategic decision-making process and a persuasive evidence-based valuation of their biotech or pharmaceutical products.

Contacts

Agency and Media:

Katie Gallagher

Account Director, PR and Marketing

617-792-3937

kgallagher@lavoiehealthscience.com

Share article on social media or email:

Mid-Atlantic BioTherapeutics Inks Deal with Wunderkind™ to Deploy Viral Outbreak Warning System (VOWS™)


Wunderkind has both deep experience in health technology, as well as expertise in leveraging AI to perform real-time identity resolution and infer patterns from deep and disparate datasets such as anonymous social media actions.

Mid-Atlantic BioTherapeutics (MABT) has engaged with New York-based technology firm Wunderkind, LLC to develop and deploy the Viral Outbreak Warning System (VOWS™) platform. VOWS™ is an artificial intelligence/machine learning (AI/ML)-driven technology system that will analyze a broad set of both public and private data in order to accurately identify viral infection hot zones and predict future outbreaks.

As all are now aware, viral pandemics represent a catastrophic medical, societal, and economic burden to humanity. Health security stakeholders such as healthcare systems, local and federal health agencies, insurance companies and NGOs have an urgent need for predictive algorithms that can better monitor potential viral outbreaks in order to mobilize effective prevention and treatment countermeasures.

There is an urgent global need right now for enhanced predictive surveillance. Resurgence of SARS-CoV-2/COVID-19 transmission is already evident as societies reopen, thus highlighting the value of implementing the VOWS™ platform as soon as possible to identify hot zones as they occur.

In order to meet this need, MABT and Wunderkind™ expect that the first working prototype of the VOWS™ platform will be available by late 2020.

VOWS™ will continuously ingest huge amounts of data from a diverse set of sources such as CDC, ClinicalTrials.gov, hospitals, insurance companies, pharmacies, PubMed, and social networks such as Facebook, Twitter, Instagram, etc. Where required, the data will be anonymized and protected utilizing trustless decentralized blockchain strategies.

Then, VOWS’s proprietary AI analysis and interactive visualization tools will identify and correlate critical ‘cause and effect’ relationships between previously unconnected variables leading to disease and outbreak trends.

Although the current focus is addressing the essential needs of the moment, the VOWS™ platform has applications beyond the current pandemic. It will also be useful for surveilling influenza and other infectious diseases (e.g., Ebola, Marburg), future novel virus outbreaks, and even opioid-related events.

There is considerable excitement about VOWS’s potential as a disease surveillance game-changer. Mid-Atlantic BioTherapeutics has received interest from a range of government and industry organizations looking to support the development and deployment of the VOWS™ technology.

Tammo Mueller, Co-Founder & CEO of Wunderkind, LLC commented, “We are very excited to work with Mid-Atlantic BioTherapeutics on VOWS™. As everyone is aware now, the potential benefits to identifying viral infection hot zones, and predicting future outbreaks cannot be overstated. We believe that our expertise in AI and Blockchain will allow us to rapidly deliver a first iteration of the platform.”

David Jobes, Ph.D., Co-Founder & President of Mid-Atlantic BioTherapeutics noted that “It didn’t take long for us to realize that Wunderkind was the right choice to be our VOWS™ technology partner. Not only do they have deep experience in various aspects of health technology, their expertise also includes leveraging AI to perform real-time identity resolution and infer patterns from deep and disparate datasets such as anonymous social media actions. They have the toolbox we needed.”

About Mid-Atlantic BioTherapeutics

Mid-Atlantic BioTherapeutics (http://mabt.us) was founded in 2011 with the mission of eradicating infectious diseases. MABT is a clinical-stage pharmaceutical company focused on the clinical development and commercialization of novel anti-infective approaches such as the patented IMT504 technology platform that harnesses the body’s own immune response to fight off infections. The company is actively addressing the growing antibiotic resistance problems and creating a revolutionary treatment paradigm for viral diseases, emerging infectious diseases and biodefense.

About Wunderkind™

Wunderkind™ (http://wunderkind.nyc) is a boutique technology consultancy and product studio that provides guidance and collaboration from the formulation of business and product strategies all the way to final implementation for a diverse set of clients in healthcare, data-driven marketing, commerce, finance, and digital transformation & AI. Wunderkind™ creates near- and long-term strategies for clients to stay ahead of marketplace disruption through the design and deployment of innovative solutions that utilize emerging technologies such as AI and blockchain.

Share article on social media or email:

Ortho Sport & Spine Physicians Invests in New Technology That Allows Patients Same Day Outpatient Diagnosis and Treatment


News Image

With the new NanoScope system, our specialists can now arthroscopically enter, visualize, and treat joints and areas we were previously unable to be safely worked, says Dr. Phillip Langer – Medical Director of Orthopedic Sports Medicine at Ortho Sport & Spine Physicians

Ortho Sport & Spine Physicians is a leading orthopedic and sports medicine practice, serving patients throughout the greater Atlanta metropolitan area and the southeastern United States. Their expert medical team specializes in providing cutting-edge, minimally invasive treatments for complex neck and spine problems, as well as sports-related injuries and conditions. In that spirit, Dr. Langer has begun utilizing the revolutionary NanoScope™ visualization system, which is a needle-sized, 1.9 mm chip-on-tip scope. It aids surgeons in diagnosing conditions such as arthritis and cartilage injuries and can even facilitate orthopedic procedures in joints, such as the shoulder, knee, elbow, wrist and ankle. Ortho Sport & Spine Physicians has long been a leader in using innovative techniques to deliver the most advanced care to patients to improve their experience and outcomes. This advanced system is a real differentiator for the practice, as the NanoScope is still a relatively new technology.

The NanoScope visualization system, developed and manufactured by Arthrex Inc. (Naples, FL), combines leading-edge technology in imaging sensors, LED light and image management that allows surgeons to perform minimally invasive arthroscopy and guide injections in tighter joint spaces that have previously been difficult to visualize. The NanoScope system allows for high-resolution visualization.

“With the new NanoScope system, our specialists can now arthroscopically enter, visualize, and treat joints and areas we were previously unable to be safely worked. This is the future of sports medicine,” says Dr. Phillip Langer – Medical Director of Orthopedic Sports Medicine at Ortho Sport & Spine Physicians

More about Ortho Sport & Spine Physicians:

Ortho Sport & Spine Physicians has multiple locations in the Atlanta area, throughout Georgia and in Charleston, SC. This practice is nationally recognized in orthopedic sports medicine and interventional spine treatment, providing exceptional and personalized care to all patients. They utilize cutting-edge, minimally invasive treatments for complex neck, spine problems and sports injuries. Their lower patient-to-provider ratio, experienced physicians, state-of-the-art facilities and equipment set them apart from other spine, sports medicine and orthopedic practices.

For more information about the services provided by Ortho Sport & Spine Physicians, please call their office at 678-752-7246, or visit their website at http://www.orthosportandspine.com.

Share article on social media or email: